Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues - PubMed (original) (raw)
. 1990 May 25;265(15):8519-24.
Affiliations
- PMID: 2341393
Free article
Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues
T Mizuochi et al. J Biol Chem. 1990.
Free article
Abstract
The N-linked oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus 1 derived from chronically infected lymphoblastoid (H9) cells have been investigated by enzymatic microsequencing after release from protein by hydrazinolysis, labeling with NaB3H4, and chromatography on adsorbent columns of Phaseolus vulgaris erythrophytohemagglutinin and Ricinus communis agglutinin (Mr 120,000) and on Bio-Gel P-4. A substantially greater diversity of oligosaccharide structures was detected than among those released by hydrazinolysis from recombinant gp120 produced in Chinese hamster ovary cells and investigated by similar procedures (Mizuochi, T., Spellman, M.W., Larkin, M., Solomon, J., Basa, L.J., and Feizi, T. (1988) Biochem J. 254, 599-603) and among those released by endoglycosidases from virus-derived gp120 isolated from infected H9 cells after metabolic labeling with D-[2-3H]mannose or D-[6-3H]glucosamine (Geyer, H., Holschbach, L., Hunsmann, G., and Schneider, J. (1988) J. Biol. Chem. 263, 11760-11767). In this study, 16% of the oligosaccharides were identified as complex-type bi-, tri-, and tetraantennary sialo-oligosaccharides with bisecting N-acetylglucosamine residues. Such structures were lacking on recombinant gp120 and could not be detected on the metabolically labeled, virus-derived glycoprotein. As in the earlier investigations, complex-type chains lacking bisecting N-acetylglucosamine residues, hybrid-type chains, and a series of high mannose-type structures with 5-9 mannose residues were identified. In addition, an array of complex-type chains having one or more outer chains with beta-galactosyl residues were detected in this study, but with additional substitutions that require further investigation. The number of potential N-glycosylation sites on gp120 is on the order of 20, but the oligosaccharide structures are far more numerous. Thus, the salient conclusion from this and earlier investigations is that alternative structures occur on at least some of the glycosylation sites and that numerous glycosylation variants of this glycoprotein are produced even within a single cell line. Since the glycosylation is the product of host cell glycosyltransferases, an even greater number of glycosylation variants of gp120 are predicted to arise from the heterogeneous cell populations harboring the virus in in vivo infection.
Similar articles
- Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells.
Mizuochi T, Spellman MW, Larkin M, Solomon J, Basa LJ, Feizi T. Mizuochi T, et al. Biochem J. 1988 Sep 1;254(2):599-603. doi: 10.1042/bj2540599. Biochem J. 1988. PMID: 2845957 Free PMC article. - [New anti-HIV drug which binds the oligosaccharides of HIV envelope glycoprotein].
Mizuochi T, Nakata M. Mizuochi T, et al. Nihon Rinsho. 1995 Sep;53(9):2340-9. Nihon Rinsho. 1995. PMID: 7474402 Review. Japanese.
Cited by
- Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry.
Go EP, Hewawasam G, Liao HX, Chen H, Ping LH, Anderson JA, Hua DC, Haynes BF, Desaire H. Go EP, et al. J Virol. 2011 Aug;85(16):8270-84. doi: 10.1128/JVI.05053-11. Epub 2011 Jun 8. J Virol. 2011. PMID: 21653661 Free PMC article. - Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.
Galili U. Galili U. Med Res Arch. 2021 Jul;9(7):2481. doi: 10.18103/mra.v9i7.2481. Epub 2021 Jul 10. Med Res Arch. 2021. PMID: 34853815 Free PMC article. - HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody.
Toda S, Ishii N, Okada E, Kusakabe KI, Arai H, Hamajima K, Gorai I, Nishioka K, Okuda K. Toda S, et al. Immunology. 1997 Sep;92(1):111-7. doi: 10.1046/j.1365-2567.1997.00307.x. Immunology. 1997. PMID: 9370932 Free PMC article. - Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes.
Galili U. Galili U. Vaccine. 2020 Sep 29;38(42):6487-6499. doi: 10.1016/j.vaccine.2020.08.032. Epub 2020 Aug 19. Vaccine. 2020. PMID: 32907757 Free PMC article. Review. - Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein.
Earl PL, Moss B, Doms RW. Earl PL, et al. J Virol. 1991 Apr;65(4):2047-55. doi: 10.1128/JVI.65.4.2047-2055.1991. J Virol. 1991. PMID: 1900540 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials